The effect of blood transfusion protocol on retinopathy of prematurity: A prospective, randomized study

Pediatrics

Volumn 104, Issue 3 I, 1999, Pages 514-518

  Brooks, Steven E ^a   Marcus, Dennis M ^a   Gillis, Delores ^a   Pirie, Elizabeth ^a   Johnson, Maribeth H ^a   Bhatia, Jatinder ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Blood transfusion; Hematocrit; Prematurity; Retinopathy of prematurity

Indexed keywords

HEMOGLOBIN;

ANEMIA; ARTICLE; CHILD GROWTH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; ERYTHROCYTE TRANSFUSION; HEMATOCRIT; HUMAN; INFANT; MORBIDITY; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINOPATHY; RISK FACTOR;

EID: 0032881530     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.104.3.514     Document Type: Article

References (30)

1. Terry TL. Extreme prematurity and fibroblastic overgrowth of persistent vascular sheath behind each crystalline lens. Am J Ophthalmol. 1942;24:203-204
2. Flynn JT, O'Grady GE, Herrera J, et al. Retrolental fibroplasia. I. Clinical observations. Arch Ophthalmol. 1977;95:217-223
3. Palmer EA, Flynn JT, Hardy RJ, et al. Incidence and early course of retinopathy of prematurity. Ophthalmology. 1991;98:1628-1640
4. The Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Arch Ophthalmol. 1984;102:1130-1134
5. Patz A, Hoeck LE, De La Cruz E. Studies on the effect of high oxygen administration in retrolental fibroplasia. I. Nursery observations. Am J Ophthalmol. 1952;35:1248-1252
6. Kinsey V, Hemphill FM. Preliminary report of a cooperative study of retrolental fibroplasia. Am J Ophthalmol. 1955;40:166-174
7. Patz A, Eastham A, Higginbotham DH, et al. Oxygen studies in retrolental fibroplasia. II. Production of the microscopic changes of retrolental fibroplasia in experimental animals. Am J Ophthalmol. 1953;36: 1511-1522
8. Ashton N. Animal experiments in retrolental fibroplasia. Trans Am Acad Ophthalmol Otolaryngol. 1954;58:51-54
9. Phelps DL. Retinopathy of prematurity: an estimate of vision loss in the United States: 1979. Pediatrics. 1981;67:924-926
10. Javitt J, Dei Cas R, Chiang Y-P. Cost-effectiveness of screening and cryotherapy for threshold retinopathy of prematurity. Pediatrics. 1993; 91:859-866
11. Gunn TR, Easdown J, Outerbridge EW, Aranda JV. Risk factors in retrolental fibroplasia. Pediatrics. 1980;65:1096-1100
12. Hammer ME, Mullen PW, Ferguson JG, Pai S, Cosby C, Jackson KL. Logistic analysis of risk factors in acute retinopathy of prematurity. Am J Ophthalmol. 1986;102:1-6
13. Koerner F, Bossi E, Wetzel C, Flury B. Retinopathy of prematurity: influence of gestational age and retinal maturity on the statistical behavior of risk factors. Graefes Arch Clin Exp Ophthalmol. 1986;224:40-45
14. Gallo JE, Jacobson L, Broberger U. Perinatal factors associated with retinopathy of prematurity. Acta Paediatr. 1993;82:829-834
15. Cooke RWI, Clark D, Hickey-Dwyer M, Weindling AM. The apparent role of blood transfusions in the development of retinopathy of prematurity. Eur J Pediatr. 1993;152:833-836
16. Sacks LM, Schaffer DB, Anday EK, Peckham GL, Delivoria-Papadopoulos M. Retrolental fibroplasia and blood transfusion in very low-birth-weight infants. Pediatrics. 1981;68:770-774
17. Aranda JV, Clark TE, Maniello R, Outerbridge EW. Blood transfusion (BT): possible potentiating risk factor in retrolental fibroplasia. Pediatr Res. 1975;9:362
18. Clark C, Gibbs JAH, Maniello R, Outerbridge EW, Aranda JV. Blood transfusion: a possible risk factor in retrolental fibroplasia. Acta Paediatr Scand. 1981;70:535-539
19. Hesse L, Eberl W, Schlaud M, Poets CF. Blood transfusion: iron load and retinopathy of prematurity. Eur J Pediatr. 1997;156:465-470
20. Inder TE, Clemett RS, Austin NC, Graham P, Darlow BA. High iron status in very low birth weight infants is associated with an increased risk of retinopathy of prematurity. J Pediatr. 1997;131:541-544
21. Bifano EM, Curran TR. Minimizing donor blood exposure in the neonatal intensive care unit: current trends and future prospects. Clin Perinatol. 1995;22:657-669
22. Levy GJ, Strauss RG, Hume H, et al. National survey of neonatal transfusion practices. I. Red blood cell therapy. Pediatrics. 1993;91: 523-529
23. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity. Arch Ophthalmol 1988;106:471-479
24. Sullivan JL. Iron, plasma antioxidants, and the oxygen radical disease of prematurity. Am J Dis Child. 1988;142:1341-1344
25. Flynn JT, Bancalari E, Bachynski BN, et al. Retinopathy of prematurity: diagnosis, severity, and natural history. Ophthalmology. 1987;94:620-629
26. Shannon KM, Keith JF, Mentzer WC, et al. Recombinant human erythropoietin stimulates erythropoeisis and reduces transfusions in very low birth weight preterm infants. Pediatrics. 1995;95:1-8
27. Schaffer DB, Palmer EA, Plotsky DF, et al. Prognostic factors in the natural course of retinopathy of prematurity. Ophthalmology. 1993;100: 230-237
28. Shastry BS, Pendergast SD, Hartzer MK, Liu X, Trese MT. Identification of missense mutation in the Norrie disease gene associated with advanced retinopathy of prematurity. Arch Ophthalmol. 1997;115:651-655
29. American Red Cross. Scientific Forum; October 1992
30. Schreiber GB. The risk of transfusion-transmitted viral infections. N Engl J Med. 1996;334:1685-1690